Molina Healthcare, Inc. reported a GAAP loss per diluted share of $3.15 and an adjusted loss per diluted share of $2.75 for the fourth quarter of 2025. The company's full year 2025 GAAP earnings per diluted share was $8.92 and adjusted earnings per diluted share was $11.03. The fourth quarter results were significantly impacted by unfavorable retroactive revenue items.

Molina Healthcare’s Q3 2025 earnings fell significantly due to elevated medical care costs, particularly in its Marketplace segment. Despite this, the company continued growing revenues and maintained profitability, driven by strength in the Medicaid business.

Molina Healthcare reported a challenging second quarter in 2025, with GAAP EPS at $4.75 and adjusted EPS at $5.48, both down year-over-year. Despite a 15% increase in premium revenue to $10.9 billion, net income decreased. The company attributed the earnings pressure to a temporary dislocation between premium rates and an accelerated medical cost trend, particularly in behavioral health, pharmacy, and inpatient/outpatient services. Full-year 2025 adjusted earnings guidance was revised downwards to no less than $19.00 per diluted share, though premium revenue guidance of approximately $42 billion was reaffirmed.

Molina Healthcare posted a strong Q1 2025 performance, driven by a 12% year-over-year increase in premium revenue and continued growth across its Medicaid, Medicare, and Marketplace segments. The company reaffirmed its full-year guidance and maintained cost efficiency despite pressures from Medicaid redeterminations.

Molina Healthcare reported strong fourth quarter 2024 results with GAAP earnings per diluted share of $4.44 and adjusted earnings per diluted share of $5.05. For the full year 2024, premium revenue increased by 19% year over year, and both GAAP and adjusted net income per diluted share saw increases of 9% and 8% respectively.

Molina Healthcare reported a strong third quarter in 2024, with GAAP earnings per diluted share of $5.65 and adjusted earnings per diluted share of $6.01. The company reaffirmed its full year 2024 guidance, expecting premium revenue of approximately $38 billion and adjusted earnings of at least $23.50 per diluted share.

Molina Healthcare reported a strong second quarter with growth in premium revenue and adjusted earnings per share. The company reaffirmed its full year 2024 earnings guidance.

Molina Healthcare reported a strong first quarter in 2024, with GAAP earnings per diluted share of $5.17 and adjusted earnings per diluted share of $5.73. The company reaffirmed its full-year 2024 guidance, expecting premium revenue of approximately $38 billion and adjusted earnings of at least $23.50 per diluted share.

Molina Healthcare reported GAAP earnings per diluted share of $3.70 and adjusted earnings per diluted share of $4.38 for Q4 2023. The company's full year 2023 GAAP earnings per diluted share was $18.77 and adjusted earnings per diluted share was $20.88.

Molina Healthcare reported a strong third quarter, with an 8% increase in premium revenue and a 7% increase in GAAP net income per diluted share. The company affirmed its full-year 2023 adjusted earnings guidance of at least $20.75 per diluted share.

Molina Healthcare reported a strong second quarter in 2023, with GAAP earnings per diluted share of $5.35 and adjusted earnings per diluted share of $5.65. The company increased its full year 2023 adjusted earnings guidance by $0.50 to at least $20.75 per diluted share.

Molina Healthcare reported a strong first quarter in 2023 with GAAP earnings per diluted share of $5.52 and adjusted earnings per diluted share of $5.81. The company's premium revenue increased by 5% compared to the first quarter of 2022, and membership grew by 4%. Molina Healthcare also raised its full-year 2023 adjusted earnings guidance to at least $20.25 per diluted share.

Molina Healthcare reported a strong fourth quarter and year-end 2022, with significant increases in premium revenue and adjusted earnings per share. The company's growth strategy and disciplined cost management contributed to a solid financial profile heading into 2023. Full year 2023 earnings guidance was issued with expected premium revenue of $32 billion and adjusted earnings of at least $19.75 per diluted share.

Molina Healthcare reported strong third-quarter results, exceeding previous guidance for revenue and earnings. The company's performance reflects the successful execution of its growth strategy and effective cost management. Increased full-year 2022 revenue and earnings guidance.

Molina Healthcare reported strong second quarter results with an 18% increase in premium revenue and GAAP earnings per diluted share of $4.25. The company increased its full year 2022 revenue and earnings guidance, reflecting confidence in its performance and growth strategy.

Molina Healthcare reported strong first quarter results, with premium revenue increasing by 19% compared to the first quarter of 2021. GAAP earnings were $4.39 per diluted share, and adjusted earnings were $4.90 per diluted share. The company increased its full year 2022 premium revenue and adjusted earnings guidance.

Molina Healthcare reported GAAP earnings per diluted share of $1.74 and adjusted earnings per diluted share of $2.88 for the fourth quarter of 2021. The company served approximately 5.2 million members as of December 31, 2021, an increase of 1.2 million members or 29% year over year.

Molina Healthcare reported a GAAP earnings per diluted share of $2.46 and an adjusted earnings per diluted share of $2.83 for Q3 2021. The company served approximately 4.8 million members as of September 30, 2021, representing a 20% increase compared to the previous year. Premium revenue for the third quarter of 2021 was approximately $6.8 billion, a 43% increase compared to the third quarter of 2020.

Molina Healthcare reported a GAAP EPS of $3.16 and an adjusted EPS of $3.40 for Q2 2021. The company served approximately 4.7 million members, an increase of 32% year-over-year. Premium revenue increased by 51% compared to the second quarter of 2020.

Molina Healthcare reported a strong first quarter in 2021, with a 33% increase in GAAP earnings per diluted share, reaching $3.89, and a 47% increase in adjusted earnings per diluted share, amounting to $4.44. The company served approximately 4.6 million members, marking a 35% increase compared to the previous year, and premium revenue rose by 47% to $6.3 billion. Due to the strong performance, Molina increased its full year 2021 premium revenue and adjusted earnings guidance.

Molina Healthcare reported a net income of $34 million for Q4 2020, or $0.56 per diluted share. The company issued its full year 2021 earnings guidance, with premium revenue growth expected to be over 25% and adjusted EPS expected to be in the range of $12.50 - $13.00.

Molina Healthcare reported a solid third quarter performance with increased premium revenue and improved medical care ratio. The company's net income increased to $185 million, and adjusted EPS reached $3.36.

Molina Healthcare reported a strong second quarter with increased net income and premium revenue. The company's performance was positively impacted by reduced demand for medical services due to the COVID-19 pandemic, which was partially offset by COVID-related premium rate refunds and direct medical costs. The company introduced full year 2021 premium revenue guidance of approximately $21.5 billion, representing 20% growth over 2020.

Molina Healthcare reported a decrease in net income for Q1 2020, with $178 million compared to $198 million in Q1 2019. However, premium revenue increased by 8.9%. The company reaffirmed its full-year 2020 earnings guidance.

Molina Healthcare reported a net income of $168 million for Q4 2019, compared to $201 million in Q4 2018. Premium revenue decreased by 7.1% to $4.1 billion. The company introduced full year 2020 earnings guidance, including GAAP earnings per diluted share of $11.20 - $11.70.